A novel Bruton's tyrosine kinase inhibitor, acalabrutinib, suppresses osteoclast differentiation and Porphyromonas gingivalis lipopolysaccharide‐induced alveolar bone resorption

2018 ◽  
Vol 90 (5) ◽  
pp. 546-554
Author(s):  
Nitin Kumar Pokhrel ◽  
Yong‐Gun Kim ◽  
Hyo Jeong Kim ◽  
Hyung Joon Kim ◽  
Ji Hye Lee ◽  
...  
Keyword(s):  
Bone Resorption ◽  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitor ◽  
Porphyromonas Gingivalis ◽  
Alveolar Bone ◽  
Kinase Inhibitor ◽  
Osteoclast Differentiation ◽  
Bruton’S Tyrosine Kinase ◽  
Bruton's Tyrosine Kinase ◽  
Porphyromonas Gingivalis Lipopolysaccharide

scholarly journals Long-term follow-up of patients with CLL treated with the selective Bruton’s tyrosine kinase inhibitor ONO/GS-4059

Blood ◽  
2017 ◽  
Vol 129 (20) ◽  
pp. 2808-2810 ◽  
Author(s):  
Harriet S. Walter ◽  
Sandrine Jayne ◽  
Simon A. Rule ◽  
Guillaume Cartron ◽  
Franck Morschhauser ◽  
...  
Keyword(s):  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitor ◽  
Kinase Inhibitor ◽  
Bruton’S Tyrosine Kinase ◽  
Bruton's Tyrosine Kinase ◽  
Long Term Follow Up
Sign in / Sign up

Export Citation Format

Share Document